The U.S. Food and Drug Administration (FDA) has accepted GlaxoSmithKlines (NYSE:GSK) biologics license application for ...

Investing.com -- The US Food and Drug Administration has accepted GlaxoSmithKline (NYSE: GSK )’s biologics license ...

The Indian stock market faces pressure from foreign capital outflow and economic weakness, with Nifty 50 down 15.82% since ...

Major pharmaceutical products and medicines have jumped in prices despite and executive order by President Bola Tinubu, ...

Global survey reveals limited awareness of shingles among adults over 50, highlighting age-related health risks and complications.

The NCSD Speakers Bureau Roster features nearly 250 public speakers, celebrities, cancer survivors, and medical professionals eligible to ...

Disney Advertising has announced that it sold out of advertising inventory for the 97th Oscars telecast. The event, hosted ...

Secondary endpoint analyses from the trials showed 'significant improvements' in patients treated with the antibody.

Despite multiple lawsuits filed by state attorneys general and a temporary block imposed by a federal judge, many ...

FDA reviews GSK depemokimab for asthma and CRSwNP, with a decision expected by December 2025. Phase 3 data shows improvements ...

GSK has joined a lengthening list of companies that have paused diversity, equity, and inclusion (DEI) targets under pressure ...

Now biometric authentication in your home state is possible when you do GST registration in another state, GSTN Advisory on ...